La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Serotonin Uptake Inhibitors (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Serotonin Uptake Inhibitors (administration & dosage) < Serotonin Uptake Inhibitors (adverse effects) < Serotonin Uptake Inhibitors (economics)  Facettes :

List of bibliographic references indexed by Serotonin Uptake Inhibitors (adverse effects)

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000932 (2014) Michel Panisset [Canada] ; Jack J. Chen ; Sean H. Rhyee ; Jill Conner ; Julie MathenaSerotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).
003847 (1998) P E Gerber [Canada] ; L D LyndSelective serotonin-reuptake inhibitor-induced movement disorders.
005646 (????) Geoff A. Bellingham [Canada] ; Philip W H. PengDuloxetine: a review of its pharmacology and use in chronic pain management.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Serotonin Uptake Inhibitors (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Serotonin Uptake Inhibitors (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Serotonin Uptake Inhibitors (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022